FDA Inspection
Paramesh Banerji Life Sciences, LLCParamesh Banerji Life Sciences, LLC – FDA Inspection, Dec 7, 2017
Record Details
This FDA Inspection record concerns Paramesh Banerji Life Sciences, LLC, with an inspection on December 7, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 134d2410-7ec4-4a4b-a46f-f1fcd74cd2ec
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1034097
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.110(c)In-process materials characteristics testing
- 21 CFR 211.25(c)Inadequate number of personnel
- 21 CFR 211.22(a)Approve or reject components, products
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(c)(1)Homeopathic drugs, assessment of stability
- 21 CFR 211.111Establishment of time limitations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Paramesh Banerji Life Sciences, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 24, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Paramesh Banerji Life Sciences, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.